Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen Sodium for OCD Symptoms in PANDAS
NCT04015596Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2020
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Aprol in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS), obsessive compulsive disorder (OCD), sponsored by Massachusetts General Hospital. Started Oct 2020; status: terminated.
02
Drugs
Aprol
03
Conditions
pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT04015596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04015596.